D.A. Holwerda, A glycopeptide from the posterior lobe of pig pituitaries. I. Isolation and characterization. Eur. J. Biochem. 28, 334–339 (1972)

PubMed  Google Scholar 

H. Land, G. Schütz, H. Schmale, D. Richter, Nucleotide sequence of cloned cDNA encoding bovine arginine vasopressin-neurophysin II precursor. Nature 295, 299–303 (1982)

PubMed  Google Scholar 

M. Glavaš, A. Gitlin-Domagalska, D. Dębowski, N. Ptaszyńska, A. Łęgowska, K. Rolka, Vasopressin and its analogues: from natural hormones to multitasking peptides. Int. J. Mol. Sci. 23, 3068 (2022). https://doi.org/10.3390/ijms23063068

Article  PubMed  PubMed Central  Google Scholar 

M. Iovino, G. Lisco, V.A. Giagulli, A. Vanacore, A. Pesce, E. Guastamacchia, G. De Pergola, V. Triggiani,Angiotensin II-vasopressin interactions in the regulation of cardiovascular functions. Evidence for an impaired hormonal sympathetic reflex in hypertension and congestive heart failure. Endocr. Metab. Immune Disord. Drug Targets 21, 1830–1844 (2021)

PubMed  Google Scholar 

S. Kim, C.H. Jo, G.H. Kim, The role of vasopressin V2 receptor in drug-induced hyponatremia. Front. Physiol. 12, 797039 (2021)

PubMed  PubMed Central  Google Scholar 

E. Łukaszyk, J. Małyszko, Copeptin: pathophysiology and potential clinical impact. Adv. Med. Sci. 60, 335–341 (2015)

PubMed  Google Scholar 

R. Acher, J. Chauvet, Y. Rouille, Dynamic processing of neuropeptides: sequential conformation shaping of neurohypophysial preprohormones during intraneuronal secretory transport. J. Mol. Neurosci. 18, 223–228 (2002)

PubMed  Google Scholar 

N.G. Morgenthaler, Copeptin: a biomarker of cardiovascular and renal function. Congest Heart Fail. 16(Suppl 1), S37–S44 (2010)

PubMed  Google Scholar 

G. Szinnai, N.G. Morgenthaler, K. Berneis, J. Struck, B. Müller, U. Keller, M. Christ-Crain, Changes in plasma copeptin, the c-terminal portion of arginine vasopressin during water deprivation and excess in healthy subjects. J. Clin. Endocrinol. Metab. 92, 3973–3978 (2007)

PubMed  Google Scholar 

S. Balanescu, P. Kopp, M.B. Gaskill, N.G. Morgenthaler, C. Schindler, J. Rutishauser, Correlation of plasma copeptin and vasopressin concentrations in hypo-, iso-, and hyperosmolar states. J. Clin. Endocrinol. Metab. 96, 1046–1052 (2011)

PubMed  Google Scholar 

J. Siegenthaler, C. Walti, S.A. Urwyler, P. Schuetz, M. Christ-Crain, Copeptin concentrations during psychological stress: the PsyCo study. Eur. J. Endocrinol. 171, 737–742 (2014)

PubMed  Google Scholar 

D.A. Gomes, R.L. de Almeida Beltrão, F.M. de Oliveira Junior, J.C. da Silva Junior, E.P.C. de Arruda, E.C. Lira, M.J.A. da Rocha, Vasopressin and copeptin release during sepsis and septic shock. Peptides 136, 170437 (2021)

PubMed  Google Scholar 

M. Christ-Crain, J. Refardt, B. Winzeler, Approach to the patient: “Utility of the Copeptin Assay”. J. Clin. Endocrinol. Metab. 107, 1727–1738 (2022)

PubMed  PubMed Central  Google Scholar 

N.G. Morgenthaler, J. Struck, S. Jochberger, M.W. Dünser, Copeptin: clinical use of a new biomarker. Trends Endocrinol. Metab. 19, 43–49 (2008)

PubMed  Google Scholar 

I. Tasevska, S. Enhörning, A. Christensson, M. Persson, P.M. Nilsson, O. Melander, Increased levels of copeptin, a surrogate marker of arginine vasopressin, are associated with an increased risk of chronic kidney disease in a general population. Am. J. Nephrol. 44, 22–28 (2016)

PubMed  Google Scholar 

C. Engelbertz, E. Brand, M. Fobker, D. Fischer, H. Pavenstädt, H. Reinecke, Elevated copeptin is a prognostic factor for mortality even in patients with renal dysfunction. Int. J. Cardiol. 221, 327–332 (2016)

PubMed  Google Scholar 

B. Afsar, Pathophysiology of copeptin in kidney disease and hypertension. Clin. Hypertens. 23, 2017 (2017). 13-017-0068-y. eCollection

Google Scholar 

W. Fenske, J. Refardt, M. Christ-Crain, Copeptin in the diagnosis of diabetes insipidus. N. Engl. J. Med. 379, 1785–1786 (2018)

PubMed  Google Scholar 

M. Christ-Crain, Vasopressin and copeptin in health and disease. Rev. Endocr. Metab. Disord. 20, 283–294 (2019)

PubMed  Google Scholar 

G.L. Robertson, E.A. Mahr, S. Athar, T. Sinha, Development and clinical application of a new method for the radioimmunoassay of arginine vasopressin in human plasma. J. Clin. Invest. 52, 2340–2352 (1973)

PubMed  PubMed Central  Google Scholar 

N.G. Morgenthaler, J. Struck, C. Alonso, A. Bergmann, Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. Clin. Chem. 52, 112–119 (2006)

PubMed  Google Scholar 

R. Ivell, D. Richter, Structure and comparison of the oxytocin and vasopressin genes from rat. Proc. Natl Acad. Sci. USA 81, 2006–2010 (1984)

PubMed  PubMed Central  Google Scholar 

M. Christ-Crain, W. Fenske, Copeptin in the diagnosis of vasopressin-dependent disorders of fluid homeostasis. Nat. Rev. Endocrinol. 12, 168–176 (2016)

PubMed  Google Scholar 

C.O. Sailer, J. Refardt, C.A. Blum, I. Schnyder, J.A. Molina-Tijeras, W. Fenske, M. Christ-Crain, Validity of different copeptin assays in the differential diagnosis of the polyuria-polydipsia syndrome. Sci. Rep. 11, 10104-021-89505-9 (2021)

Google Scholar 

D. Mu, J. Cheng, L. Qiu, X. Cheng, Copeptin as a diagnostic and prognostic biomarker in cardiovascular diseases. Front. Cardiovasc. Med. 9, 901990 (2022)

PubMed  PubMed Central  Google Scholar 

L. Bonnet, E. Marquant, J. Fromonot, I. Hamouda, J. Berbis, A. Godefroy, M. Vierge, M. Tsimaratos, R. Reynaud, Copeptin assays in children for the differential diagnosis of polyuria-polydipsia syndrome and reference levels in hospitalized children. Clin. Endocrinol. 96, 47–53 (2022)

Google Scholar 

S. Jochberger, N.G. Morgenthaler, V.D. Mayr, G. Luckner, V. Wenzel, H. Ulmer, S. Schwarz, W.R. Hasibeder, B.E. Friesenecker, M.W. Dünser, Copeptin and arginine vasopressin concentrations in critically ill patients. J. Clin. Endocrinol. Metab. 91, 4381–4386 (2006)

PubMed  Google Scholar 

R. Roussel, L. Fezeu, M. Marre, G. Velho, F. Fumeron, P. Jungers, O. Lantieri, B. Balkau, N. Bouby, L. Bankir, D.G. Bichet, Comparison between copeptin and vasopressin in a population from the community and in people with chronic kidney disease. J. Clin. Endocrinol. Metab. 99, 4656–4663 (2014)

PubMed  Google Scholar 

S.S. Bhandari, I. Loke, J.E. Davies, I.B. Squire, J. Struck, L.L. Ng, Gender and renal function influence plasma levels of copeptin in healthy individuals. Clin. Sci. 116, 257–263 (2009)

Google Scholar 

F. Piani, T. Reinicke, Y. Lytvyn, I. Melena, L.E. Lovblom, V. Lai, J. Tse, L. Cham, A. Orszag, B.A. Perkins, D.Z.I. Cherney, P. Bjornstad, Vasopressin associated with renal vascular resistance in adults with longstanding type 1 diabetes with and without diabetic kidney disease. J. Diabetes Complicat. 35, 107807 (2021)

Google Scholar 

E. Meijer, S.J. Bakker, N. Halbesma, P.E. de Jong, J. Struck, R.T. Gansevoort, Copeptin, a surrogate marker of vasopressin, is associated with microalbuminuria in a large population cohort. Kidney Int. 77, 29–36 (2010)

PubMed  Google Scholar 

D. Zittema, E. van den Berg, E. Meijer, W.E. Boertien, A.C. Muller Kobold, C.F. Franssen, P.E. de Jong, S.J. Bakker, G. Navis, R.T. Gansevoort, Kidney function and plasma copeptin levels in healthy kidney donors and autosomal dominant polycystic kidney disease patients. Clin. J. Am. Soc. Nephrol. 9, 1553–1562 (2014)

PubMed  PubMed Central  Google Scholar 

E. Meijer, S.J. Bakker, E.J. van der Jagt, G. Navis, P.E. de Jong, J. Struck, R.T. Gansevoort, Copeptin, a surrogate marker of vasopressin, is associated with disease severity in autosomal dominant polycystic kidney disease. Clin. J. Am. Soc. Nephrol. 6, 361–368 (2011)

PubMed  PubMed Central  Google Scholar 

B. Ponte, M. Pruijm, D. Ackermann, P. Vuistiner, I. Guessous, G. Ehret, H. Alwan, S. Youhanna, F. Paccaud, M. Mohaupt, A. Péchère-Bertschi, B. Vogt, M. Burnier, P.Y. Martin, O. Devuyst, M. Bochud, Copeptin is associated with kidney length, renal function, and prevalence of simple cysts in a population-based study. J. Am. Soc. Nephrol. 26, 1415–1425 (2015)

PubMed  Google Scholar 

T. Schoen, E.M. Hohmann, S. Van Der Lely, S. Aeschbacher, A. Reusser, M. Risch, L. Risch, D. Conen, Plasma copeptin levels and ambulatory blood pressure characteristics in healthy adults. J. Hypertens. 33, 1571–1579 (2015)

PubMed  Google Scholar 

R. Roussel, N. Matallah, N. Bouby, R. El Boustany, L. Potier, F. Fumeron, K. Mohammedi, B. Balkau, M. Marre, L. Bankir, G. Velho, Plasma copeptin and decline in renal function in a cohort from the community: the prospective D.E.S.I.R. study. Am. J. Nephrol. 42, 107–114 (2015)

PubMed  Google Scholar 

R. El Boustany, I. Tasevska, E. Meijer, L.M. Kieneker, S. Enhörning, G. Lefèvre, K. Mohammedi, M. Marre, F. Fumeron, B. Balkau, N. Bouby, L. Bankir, S.J. Bakker, R. Roussel, O. Melander, R.T. Gansevoort, G. Velho, Plasma copeptin and chronic kidney disease risk in 3 European cohorts from the general population. JCI Insight 3, e121479 (2018). https://doi.org/10.1172/jci.insight.121479

Article  PubMed Central  Google Scholar 

S. Enhörning, A. Christensson, O. Melander, Plasma copeptin as a predictor of kidney disease. Nephrol. Dial. Transpl. 34, 74–82 (2019)

Google Scholar 

D. Zittema, W.E. Boertien, A.P. van Beek, R.P. Dullaart, C.F. Franssen, P.E. de Jong, E. Meijer, R.T. Gansevoort, Vasopressin, copeptin, and renal concentrating capacity in patients with autosomal dominant polycystic kidney disease without renal impairment. Clin. J. Am. Soc. Nephrol. 7, 906–913 (2012)

PubMed  Google Scholar 

J.P. Arroyo, E.A. Akwo, A.S. Terker, A. Alsouqi, G. Bhave, R.C. Harris, A.M. Hung, T.A. Ikizler, Peripheral insulin resistance is associated with copeptin in patients with chronic kidney disease. Kidney360 2, 1434–1440 (2021)

PubMed  PubMed Central  Google Scholar 

V. Krane, B. Genser, M.E. Kleber, C. Drechsler, W. März, G. Delgado, B. Allolio, C. Wanner, W. Fenske, 4D and LURIC study investigators, copeptin associates with cause-specific mortality in patients with impaired renal function: results from the LURIC and the 4D study. Clin. Chem. 63, 997–1007 (2017)

PubMed  Google Scholar 

E.M. Ettema, J. Heida, N.F. Casteleijn, L. Boesten, R. Westerhuis, C.A.J.M. Gaillard, R.T. Gansevoort, C.F.M. Franssen, D. Zittema, The effect of renal function and hemodialysis treatment on plasma vasopressin and copeptin levels. Kidney Int. Rep. 2, 410–419 (2017)

PubMed  PubMed Central  Google Scholar 

W. Fenske, M. Quinkler, D. Lorenz, K. Zopf, U. Haagen, J. Papassotiriou, A.F. Pfeiffer, M. Fassnacht, S. Störk, B. Allolio, Copeptin in the differential diagnosis of the polydipsia-polyuria syndrome–revisiting the direct and indirect water deprivation tests. J. Clin. Endocrinol. Metab. 96, 1506–1515 (2011)

PubMed  Google Scholar 

S.M. Parizadeh, M. Ghandehari, M.R. Parizadeh, G.A. Ferns, M. Ghayour-Mobarhan, A. Avan, S.M. Hassanian, The diagnostic and prognostic value of copeptin in cardiovascular disease, current status, and prospective. J. Cell. Biochem. 119, 7913–7923 (2018)

PubMed  Google Scholar 

C. Kourtidou, M. Stangou, S. Marinaki, K. Tziomalos, Novel cardiovascular risk factors in patients with diabetic kidney disease. Int. J. Mol. Sci. 22, 11196 (2021). https://doi.org/10.3390/ijms222011196

Article  PubMed  PubMed Central  Google Scholar 

E. Golembiewska, A.R. Qureshi, L. Dai, B. Lindholm, O. Heimbürger, M. Söderberg, T.B. Brismar, J. Ripsweden, P. Barany, R.J. Johnson, P. Stenvinkel, Copeptin is independently associated with vascular calcification in chronic kidney disease stage 5. BMC Nephrol. 21, 43-020-1710-6 (2020)